Engineers Gate Manager LP Rhythm Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $206,652 - $363,373	13,071 New	13,071 $299,000
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $126,480 - $252,547	-20,633 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $177,856 - $286,798	20,633 New	20,633 $206,000
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $605,789 - $737,610	-32,710 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $662,377 - $1.29 Million	32,710 New	32,710 $696,000

191

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.